Clinical Trials Logo

Acne Vulgaris clinical trials

View clinical trials related to Acne Vulgaris.

Filter by:

NCT ID: NCT04224597 Not yet recruiting - Acne Vulgaris Clinical Trials

Evaluation of the Presence of Enthesitis in Patients With Acne Vulgaris

Start date: February 1, 2020
Phase:
Study type: Observational

Acne vulgaris is an inflammatory disease of the pilosebaceous unit, affecting about 85% of the young population. In the studies p. acne is a potent stimulator of the release of IFN-gamma (IFN-)) and IL-17 from CD4 + T cells, and the presence of IL-17 + cells in the perifollicular infiltrate has been shown in biopsies of inflammatory acne lesions. Therefore, acne is thought to be a Th17-related disease (1). This study was aimed to evaluate the presence of enthesitis in patients with acne vulgaris.

NCT ID: NCT03879369 Not yet recruiting - Acne Vulgaris Clinical Trials

Sexual Dysfunction in Female Patients With Adult Acne Vulgaris

Start date: May 2019
Phase:
Study type: Observational

Assessment of sexual dysfunction in adult females with acne vulgaris and its relation to other variables as quality of life, acne severity and hormonal dysfunction.

NCT ID: NCT03866447 Not yet recruiting - Acne Vulgaris Clinical Trials

Role of Vitamin D and Its Topical Analogues in Pathogenesis and Treatment of Acne Vulgaris

Start date: October 1, 2019
Phase: Phase 4
Study type: Interventional

Acne vulgaris is a chronic skin disease of the pilosebaceous unit characterized by formation of papules, pustules, comedones, nodules and cysts. It can have a major psychological burden on the patients. It develops due to blockage of the hair follicles. This is thought to occur as a result of the following four abnormal processes: a higher than normal amount of sebum production, excessive deposition of keratin leading to comedo formation, hair follicles' colonization by Propionibacterium acnes (P. acnes) and the local release of pro-inflammatory mediators. Androgens also play a role in pathogenesis either from elevated levels or exacerbated response

NCT ID: NCT03859843 Not yet recruiting - Acne Vulgaris Clinical Trials

Efficacy and Antimicrobial Activity of Platelet Rich Plasma (PRP) in Acne Vulgaris

Start date: January 10, 2020
Phase: Phase 3
Study type: Interventional

Efficacy and Antimicrobial activity of Platelet Rich Plasma (PRP) in Acne Vulgaris : A randomized controlled trial

NCT ID: NCT03602534 Not yet recruiting - Acne Vulgaris Clinical Trials

Thyroid Dysfunction in Female Patients With Acne Vulgaris: [ Relation to Other Variables ]

Start date: December 2018
Phase:
Study type: Observational

Acne is a chronic inflammatory disease of the pilo-sebaceous unit with a multi-factorial etiology. It is one of the most frequent cutaneous diseases, affecting more than eighty percent of the population at some point in their lives . Endocrine factors especially androgens and steroids are one of multiple factors provoked to be involved in pathogenesis of acne . Thyroid hormones have steroid like action that have many regulatory functions in many body organ functions including skin and pilosebaceous unit. Furthermore, subtle thyroid dysfunction was shown to have a role in many disease conditions. Thyroid hormone action on sebaceous glands is unclear. In hypothyroid states, sebocytes exhibit reduced rates of secretion that increases with thyroxine administration .

NCT ID: NCT03480503 Not yet recruiting - Acne Vulgaris Clinical Trials

Apelin12 in Acne Vulgaris

Start date: May 2018
Phase:
Study type: Observational

Acne vulgaris is a common chronic inflammatory disease of the pilosebaceous unit which is characterized by the formation of non-inflammatory open and closed comedones and inflammatory papules, pustules, nodules and cysts. It is a multifactorial disease that affects mostly adolescent population. Acne appears very early in puberty during the preteen years, often before menarche in girls. Because many adolescents have acne, it is difficult to predict which individuals are prone to severe cases. The pathogenesis of acne is complex, with strong evidence supporting the involvement of follicular hyperkeratinization, hyperactivity of the sebaceous glands, colonization of Propionibacterium acnes and yeast, and inflammation. Although the importance of androgens in the pathophysiology of acne has been supported by both clinical studies and experimental data, the research evaluating adipokines are very few in patients with acne vulgaris.

NCT ID: NCT03186222 Not yet recruiting - Acne Vulgaris Clinical Trials

Polymorphism of Extrapituitary Promoter of PRL Gene and Relationships With Serum Prolactin Levels in Acne Vulgaris.

Start date: January 2018
Phase: N/A
Study type: Observational

Acne vulgaris is one of the most common skin diseases. It is a disease of the pilosebaceous units, clinically characterized by seborrhea, comedones, papules, pustules, nodules and, in some cases, scarring.

NCT ID: NCT03185312 Not yet recruiting - Clinical trials for Vitiligo and Acne Vulgaris

Cutaneous JAK in Vitiligo and Acne Vulgaris.

Start date: January 2018
Phase: N/A
Study type: Observational

The Janus kinase/signal transducer and activator of transcription (JAK-STAT) cytokine signaling pathway is an emerging area of interest in dermatology, and emerging evidence suggests that this pathway may play a crucial role in pathogenesis of inflammatory skin disorders. Recent advances on the role of cytokines in the pathophysiology of immune mediated inflammatory diseases lead to the understanding that many pro inflammatory interleukins use JAK/STAT components for signal transduction .

NCT ID: NCT03090048 Not yet recruiting - Acne Vulgaris Clinical Trials

Vitamin A and Azithromycin for Acne Vulgaris

Start date: April 1, 2021
Phase: Early Phase 1
Study type: Interventional

Patients seen with acne lesions not having responded to existing treatments will be offered a placebo or a topical preparation consisting of Vitamin A USP with or without Azithromycin for a duration of 4-6 months USP for the objective of resolving the lesions without systemic side effects and via weekly follow-ups.

NCT ID: NCT02537483 Not yet recruiting - Acne Vulgaris Clinical Trials

A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris

Start date: October 2015
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to compare the efficacy, safety, and tolerability of IDP-120 Gel to IDP-120 Component A, IDP-120 Component B, and IDP-120 Vehicle Gel in subjects with moderate to severe acne vulgaris.